Amgen, Inc. (AMGN)
338.26
+10.00
(+3.05%)
USD |
NASDAQ |
Jun 03, 16:00
342.00
+3.74
(+1.11%)
After-Hours: 19:59
Amgen EPS Diluted (Quarterly) : 3.344 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Gilead Sciences, Inc. | 1.612 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| AbbVie, Inc. | 0.3861 |
| Viridian Therapeutics, Inc. | -1.026 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.819B |
| Revenue (Quarterly) | 8.654B |
| Total Expenses (Quarterly) | 6.835B |
| Enterprise Value | 222.45B |
| Gross Profit Margin (Quarterly) | 68.29% |
| Profit Margin (Quarterly) | 21.02% |
| Earnings Yield | 4.25% |
| Operating Earnings Yield | 6.45% |
| Normalized Earnings Yield | 4.707 |